https://www.prnewswire.com/il/news-releases/scinai-announces-signing-of-loan-restructuring-agreement-with-european-investment-bank-converting-approximately-29-million-of-debt-to-preferred-equity-convertible-into-19-5-common-equity-302220743.html
Scinai Announces Signing of Loan Restructuring Agreement with European Investment Bank; Converting...
/PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) (the "Company"), a biopharmaceutical company focused on developing inflammation and immunology...
european investment bank